Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Valeant Pharmaceuticals (VRX.TO)

BUY
Likes the generic drug space, but prefers Teva. Govts will be pressured for lower health costs.
WAIT
A favourite. If you own hold, but don't buy yet. Strong earnings growth in the past 3 years and expects it to continue
DON'T BUY
Well run company and has several products in the works, but prefers spreading bio techs around
BUY
30% earnings growth make this reasonably priced
DON'T BUY
A sustainable company
BUY
Good company
BUY
Strong product pipeline. Good management
BUY ON WEAKNESS
If republicans get in, could be a problem. Be careful of bio stocks
BUY
Downturn/Competition got approval on similar drug
Showing 706 to 714 of 714 entries